"name","instanceType","uuid:ID","text","id","description","label"
"OBJ1","Objective","47e4c506-5961-4011-8ed2-0b392b7f301d","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Objective_1","Main objective",""
"OBJ2","Objective","a35d01f3-5918-46b2-98e1-fe127e46e4d0","To document the safety profile of the xanomeline TTS.","Objective_2","Safety",""
"OBJ3","Objective","077145ab-1f35-4c38-8828-16af85168e19","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Objective_3","Behaviour",""
